Site içinde arama yapın | Scenario.press

bir ses eklendi Health

2025-09-25 14:08:30 -

Global Neuropathic Pain Market Forecasted to Grow at CAGR of 6.8% Through 2034 | Leading Players Include Pfizer & Sanofi

The global neuropathic pain market is poised for significant growth, valued at USD 6,316.6 million in 2024 and projected to reach USD 14,538.7 million by 2034, reflecting a compound annual growth rate (CAGR) of 5.7% over the forecast period. This expansion is driven by the rising prevalence of chronic conditions such as diabetes and cancer, an aging global population, and advancements in...

0 Yorumlar 0 hisse senetleri 100 Views